Thursday, March 19, 2015 10:12:25 AM
Certain forms of cannabis are potent medicine with few or no psychoactive effects. Even the US Surgeon General Vivek Murthy has spoken out about its potential benefits, saying: "We have some preliminary data showing that for certain medical conditions and symptoms, marijuana can be helpful." His statement echoes a growing sentiment in the medical and scientific communities that the health benefits of marijuana should no longer be ignored. The American Academy of Pediatrics (AAP) has also given strong support for research and development as well as a "review of policies promoting research on the medical use of these compounds."
At present, 23 states have legalized medical marijuana.23 Another 11 states have pending legislation for 2015.24 On a federal level, however, the herb is still considered a Schedule 1 controlled substance (other Schedule 1 drugs include heroin, LSD, ecstasy, methaqualone, and peyote). Ironically, oxycodone, fentanyl, and meperidine (Demerol), which are among the most commonly abused opioids and leading causes of opioid overdose deaths, are Schedule II drugs, meaning they should technically be less dangerous than marijuana. Meanwhile, until recently certain opioid prescription drugs such as Vicodin were classified as Schedule III substances, which are defined as "drugs with a moderate to low potential for physical and psychological dependence."
A wealth of research shows marijuana does have outstanding promise as a medicinal plant, largely due to its cannabidiol (CBD) content. Cannabinoids interact with your body by way of naturally occurring cannabinoid receptors embedded in cell membranes throughout your body. There are cannabinoid receptors in your brain, lungs, liver, kidneys, immune system, and more. Both the therapeutic and psychoactive properties of marijuana occur when a cannabinoid activates a cannabinoid receptor.
Research is still ongoing on just how extensive their impact is on our health, but to date it's known that cannabinoid receptors play an important role in many body processes, including metabolic regulation, cravings, pain, anxiety, bone growth, and immune function. To learn more about the legal parameters of using medical cannabis in your state, check out ProCon.org's website.25 I also recommend listening to my interview with Dr. Allan Frankel, a board-certified internist in California, who has treated patients with medical cannabis for the past eight years."
Recent CBDS News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 09:58:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 09:34:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 07:44:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 07:24:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 06:46:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 06:39:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 06:22:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 05:09:11 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/07/2024 08:05:49 PM
- Form 144/A - Report of proposed sale of securities: [Amend] • Edgar (US Regulatory) • 02/06/2024 08:19:32 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/01/2024 12:01:39 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 08:08:10 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 04:21:57 PM
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 09/05/2023 07:09:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 04:03:07 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM